Looking to the Future: Planning Ahead for Post-Trial Access to Create Equitable Solutions for All Stakeholders Involved
Time: 12:00 pm
day: Conf Day Two
Details:
- Ethical considerations on the decisions to provide post-trial access to investigational medicine
- Defining an effective transition strategy with minimal disruption to patient care, regulatory compliance, and overall program efficiency through careful coordination and early engagement with clinical trial teams
- Understanding the different post-trial access regulations and policies from country-to-country and factors to consider when determining where to provide post-trial access
